vs
Side-by-side financial comparison of Lucid Diagnostics Inc. (LUCD) and Vuzix Corp (VUZI). Click either name above to swap in a different company.
Vuzix Corp is the larger business by last-quarter revenue ($2.2M vs $1.2M, roughly 1.9× Lucid Diagnostics Inc.). Vuzix Corp runs the higher net margin — -384.2% vs -858.5%, a 474.4% gap on every dollar of revenue. On growth, Vuzix Corp posted the faster year-over-year revenue change (76.4% vs 3.3%). Over the past eight quarters, Lucid Diagnostics Inc.'s revenue compounded faster (7.9% CAGR vs 5.8%).
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
Vuzix Corporation is an American multinational technology company headquartered in Rochester, New York and founded by Paul Travers in 1997. Vuzix is a supplier of smartglasses and augmented reality display technology. Vuzix manufactures and sells computer display devices and software. Vuzix head-mounted displays are marketed towards mobile and immersive augmented reality applications, such as 3D gaming, manufacturing training, and military tactical equipment. On January 5, 2015, Intel acquire...
LUCD vs VUZI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $2.2M |
| Net Profit | $-10.4M | $-8.6M |
| Gross Margin | — | 16.7% |
| Operating Margin | -971.0% | -373.9% |
| Net Margin | -858.5% | -384.2% |
| Revenue YoY | 3.3% | 76.4% |
| Net Profit YoY | 16.0% | 36.9% |
| EPS (diluted) | $-0.10 | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.2M | ||
| Q3 25 | $1.2M | $1.2M | ||
| Q2 25 | $1.2M | $1.3M | ||
| Q1 25 | $828.0K | $1.6M | ||
| Q4 24 | $1.2M | $1.3M | ||
| Q3 24 | $1.2M | $1.4M | ||
| Q2 24 | $976.0K | $1.1M | ||
| Q1 24 | $1.0M | $2.0M |
| Q4 25 | — | $-8.6M | ||
| Q3 25 | $-10.4M | $-7.4M | ||
| Q2 25 | $-4.4M | $-7.7M | ||
| Q1 25 | $-26.9M | $-8.6M | ||
| Q4 24 | $-11.5M | $-13.7M | ||
| Q3 24 | $-12.4M | $-9.2M | ||
| Q2 24 | $-11.0M | $-40.6M | ||
| Q1 24 | $-10.6M | $-10.0M |
| Q4 25 | — | 16.7% | ||
| Q3 25 | — | -35.4% | ||
| Q2 25 | — | -58.7% | ||
| Q1 25 | — | -16.8% | ||
| Q4 24 | — | -389.6% | ||
| Q3 24 | — | -18.8% | ||
| Q2 24 | — | -30.5% | ||
| Q1 24 | — | -2.6% |
| Q4 25 | — | -373.9% | ||
| Q3 25 | -971.0% | -645.5% | ||
| Q2 25 | -978.8% | -606.1% | ||
| Q1 25 | -1508.1% | -555.0% | ||
| Q4 24 | -1033.8% | -1089.2% | ||
| Q3 24 | -997.8% | -670.9% | ||
| Q2 24 | -1146.7% | -3726.5% | ||
| Q1 24 | -1078.1% | -503.6% |
| Q4 25 | — | -384.2% | ||
| Q3 25 | -858.5% | -633.4% | ||
| Q2 25 | -381.7% | -591.5% | ||
| Q1 25 | -3249.8% | -546.4% | ||
| Q4 24 | -964.2% | -1074.0% | ||
| Q3 24 | -1055.5% | -665.4% | ||
| Q2 24 | -1127.6% | -3715.6% | ||
| Q1 24 | -1060.1% | -501.4% |
| Q4 25 | — | $-0.12 | ||
| Q3 25 | $-0.10 | $-0.09 | ||
| Q2 25 | $-0.08 | $-0.10 | ||
| Q1 25 | $-0.52 | $-0.11 | ||
| Q4 24 | $-0.17 | $-0.16 | ||
| Q3 24 | $-0.25 | $-0.14 | ||
| Q2 24 | $-0.23 | $-0.62 | ||
| Q1 24 | $-0.40 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | $21.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $25.8M | $24.7M |
| Total Assets | $53.2M | $40.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $21.2M | ||
| Q3 25 | $47.3M | $22.6M | ||
| Q2 25 | $31.1M | $17.5M | ||
| Q1 25 | $25.2M | $15.2M | ||
| Q4 24 | $22.4M | $18.2M | ||
| Q3 24 | $14.5M | $14.3M | ||
| Q2 24 | $24.9M | $9.9M | ||
| Q1 24 | $24.8M | $16.5M |
| Q4 25 | — | $24.7M | ||
| Q3 25 | $25.8M | $27.9M | ||
| Q2 25 | $7.9M | $28.9M | ||
| Q1 25 | $-5.4M | $32.8M | ||
| Q4 24 | $5.4M | $37.3M | ||
| Q3 24 | $6.3M | $39.6M | ||
| Q2 24 | $16.0M | $35.4M | ||
| Q1 24 | $11.9M | $73.1M |
| Q4 25 | — | $40.1M | ||
| Q3 25 | $53.2M | $42.5M | ||
| Q2 25 | $38.7M | $36.9M | ||
| Q1 25 | $32.8M | $35.8M | ||
| Q4 24 | $30.7M | $39.4M | ||
| Q3 24 | $22.6M | $41.8M | ||
| Q2 24 | $34.1M | $38.2M | ||
| Q1 24 | $32.0M | $77.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.9M | $-5.6M |
| Free Cash FlowOCF − Capex | — | $-5.9M |
| FCF MarginFCF / Revenue | — | -263.5% |
| Capex IntensityCapex / Revenue | — | 15.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-20.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-5.6M | ||
| Q3 25 | $-10.9M | $-5.0M | ||
| Q2 25 | $-10.5M | $-4.8M | ||
| Q1 25 | $-12.5M | $-3.5M | ||
| Q4 24 | $-9.9M | $-4.0M | ||
| Q3 24 | $-10.2M | $-5.3M | ||
| Q2 24 | $-11.5M | $-5.6M | ||
| Q1 24 | $-12.6M | $-8.8M |
| Q4 25 | — | $-5.9M | ||
| Q3 25 | — | $-5.3M | ||
| Q2 25 | — | $-5.5M | ||
| Q1 25 | — | $-4.1M | ||
| Q4 24 | — | $-4.3M | ||
| Q3 24 | — | $-5.5M | ||
| Q2 24 | — | $-6.5M | ||
| Q1 24 | — | $-8.9M |
| Q4 25 | — | -263.5% | ||
| Q3 25 | — | -457.4% | ||
| Q2 25 | — | -425.6% | ||
| Q1 25 | — | -257.2% | ||
| Q4 24 | — | -334.4% | ||
| Q3 24 | — | -395.1% | ||
| Q2 24 | — | -591.4% | ||
| Q1 24 | — | -444.4% |
| Q4 25 | — | 15.8% | ||
| Q3 25 | — | 27.4% | ||
| Q2 25 | — | 56.1% | ||
| Q1 25 | — | 38.8% | ||
| Q4 24 | — | 18.1% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 75.8% | ||
| Q1 24 | — | 5.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
